The science behind the patch Transdermal patches are widely used in healthcare for pain-free, controlled, or consistent drug delivery
That single figure from RepData research fielded on behalf of PepsiCo, explains why protein feels less like a trend and more like a requirement
However, it can also be a symptom of gastrointestinal cancer
There is currently no specific contraindication to using GLP-1 receptor agonists in people with Crohn's disease, but this decision requires careful individualised assessment
While cross-trial comparisons come with important caveats patient populations, trial designs, and dose titrations all differ the overall pattern is clear
If you're currently taking semaglutide or tirzepatide and doing well, there's no reason to wait